Literature DB >> 21228324

The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones.

Nicolas A Gillet1, Nirav Malani, Anat Melamed, Niall Gormley, Richard Carter, David Bentley, Charles Berry, Frederic D Bushman, Graham P Taylor, Charles R M Bangham.   

Abstract

Human T-lymphotropic virus type 1 (HTLV-1) persists by driving clonal proliferation of infected T lymphocytes. A high proviral load predisposes to HTLV-1-associated diseases. Yet the reasons for the variation within and between persons in the abundance of HTLV-1-infected clones remain unknown. We devised a high-throughput protocol to map the genomic location and quantify the abundance of > 91,000 unique insertion sites of the provirus from 61 HTLV-1(+) persons and > 2100 sites from in vitro infection. We show that a typical HTLV-1-infected host carries between 500 and 5000 unique insertion sites. We demonstrate that negative selection dominates during chronic infection, favoring establishment of proviruses integrated in transcriptionally silenced DNA: this selection is significantly stronger in asymptomatic carriers. We define a parameter, the oligoclonality index, to quantify clonality. The high proviral load characteristic of HTLV-1-associated inflammatory disease results from a larger number of unique insertion sites than in asymptomatic carriers and not, as previously thought, from a difference in clonality. The abundance of established HTLV-1 clones is determined by genomic features of the host DNA flanking the provirus. HTLV-1 clonal expansion in vivo is favored by orientation of the provirus in the same sense as the nearest host gene.

Entities:  

Mesh:

Year:  2011        PMID: 21228324      PMCID: PMC3062313          DOI: 10.1182/blood-2010-10-312926

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

1.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.

Authors:  M Nagai; K Usuku; W Matsumoto; D Kodama; N Takenouchi; T Moritoyo; S Hashiguchi; M Ichinose; C R Bangham; S Izumo; M Osame
Journal:  J Neurovirol       Date:  1998-12       Impact factor: 2.643

2.  Combinatorial patterns of histone acetylations and methylations in the human genome.

Authors:  Zhibin Wang; Chongzhi Zang; Jeffrey A Rosenfeld; Dustin E Schones; Artem Barski; Suresh Cuddapah; Kairong Cui; Tae-Young Roh; Weiqun Peng; Michael Q Zhang; Keji Zhao
Journal:  Nat Genet       Date:  2008-06-15       Impact factor: 38.330

3.  HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.

Authors:  K J Jeffery; K Usuku; S E Hall; W Matsumoto; G P Taylor; J Procter; M Bunce; G S Ogg; K I Welsh; J N Weber; A L Lloyd; M A Nowak; M Nagai; D Kodama; S Izumo; M Osame; C R Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states.

Authors:  Keitarou Doi; Xiaolin Wu; Yuko Taniguchi; Jun-ichirou Yasunaga; Yorifumi Satou; Akihiko Okayama; Kisato Nosaka; Masao Matsuoka
Journal:  Blood       Date:  2005-04-19       Impact factor: 22.113

5.  Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.

Authors:  David Derse; Bruce Crise; Yuan Li; Gerald Princler; Nicole Lum; Claudia Stewart; Connor F McGrath; Stephen H Hughes; David J Munroe; Xiaolin Wu
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

6.  Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.

Authors:  K Etoh; S Tamiya; K Yamaguchi; A Okayama; H Tsubouchi; T Ideta; N Mueller; K Takatsuki; M Matsuoka
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

7.  Integration of human T-cell leukemia virus type 1 in genes of leukemia cells of patients with adult T-cell leukemia.

Authors:  Shuji Hanai; Takayuki Nitta; Momoko Shoda; Masakazu Tanaka; Naomi Iso; Izuru Mizoguchi; Shinji Yashiki; Shunro Sonoda; Yuichi Hasegawa; Toshiro Nagasawa; Masanao Miwa
Journal:  Cancer Sci       Date:  2004-04       Impact factor: 6.716

8.  Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough.

Authors:  Yefei Han; Yijie B Lin; Wenfeng An; Jie Xu; Hung-Chih Yang; Karen O'Connell; Dominic Dordai; Jef D Boeke; Janet D Siliciano; Robert F Siliciano
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

9.  In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection.

Authors:  Becca Asquith; Yan Zhang; Angelina J Mosley; Catherine M de Lara; Diana L Wallace; Andrew Worth; Lambrini Kaftantzi; Kiran Meekings; George E Griffin; Yuetsu Tanaka; David F Tough; Peter C Beverley; Graham P Taylor; Derek C Macallan; Charles R M Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

10.  How does HTLV-I persist despite a strong cell-mediated immune response?

Authors:  Becca Asquith; Charles R M Bangham
Journal:  Trends Immunol       Date:  2007-11-26       Impact factor: 16.687

View more
  161 in total

1.  Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia: continuity from carrier status to smoldering ATL.

Authors:  Shimeru Kamihira; Masako Iwanaga; Yuko Doi; Daisuke Sasaki; Sayaka Mori; Kazuto Tsurda; Kazuhiro Nagai; Naoki Uno; Hiroo Hasegawa; Katsunori Yanagihara; Yoshitomo Morinaga; Kunihiro Tsukasaki; Hiroaki Taniguchi
Journal:  Int J Hematol       Date:  2012-03-28       Impact factor: 2.490

2.  Analysis of host genetic diversity and viral entry as sources of between-host variation in viral load.

Authors:  Andrew R Wargo; Alison M Kell; Robert J Scott; Gary H Thorgaard; Gael Kurath
Journal:  Virus Res       Date:  2012-01-30       Impact factor: 3.303

3.  Establishment of a simplified inverse polymerase chain reaction method for diagnosis of enzootic bovine leukosis.

Authors:  Asami Nishimori; Kiyohiko Andoh; Yuichi Matsuura; Asuka Kumagai; Shinichi Hatama
Journal:  Arch Virol       Date:  2021-01-24       Impact factor: 2.574

4.  A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease.

Authors:  Everett H Meyer; Andro R Hsu; Joanna Liliental; Andrea Löhr; Mareike Florek; James L Zehnder; Sam Strober; Philip Lavori; David B Miklos; David S Johnson; Robert S Negrin
Journal:  Blood       Date:  2013-05-07       Impact factor: 22.113

5.  Inhibition of IκBα phosphorylation potentiates regulated cell death induced by azidothymidine in HTLV-1 infected cells.

Authors:  Claudia Matteucci; Francesca Marino-Merlo; Antonella Minutolo; Emanuela Balestrieri; Elena Valletta; Beatrice Macchi; Antonio Mastino; Sandro Grelli
Journal:  Cell Death Discov       Date:  2020-02-18

6.  Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions.

Authors:  Oriana Romano; Ingrid Cifola; Valentina Poletti; Marco Severgnini; Clelia Peano; Gianluca De Bellis; Fulvio Mavilio; Annarita Miccio
Journal:  J Vis Exp       Date:  2017-05-28       Impact factor: 1.355

7.  Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion.

Authors:  Eric Oksenhendler; Jocelyn Turpin; Raphael Lhote; Olivier Cassar; Jean-Michel Cayuela; Claire Fieschi; Lionel Galicier; Veronique Meignin; Charles Bangham; Antoine Gessain
Journal:  Int J Hematol       Date:  2017-01-30       Impact factor: 2.490

8.  RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.

Authors:  Hsin-Ching Lin; Peter J Simon; Riza M Ysla; Steven L Zeichner; Gary Brewer; Arnold B Rabson
Journal:  Virology       Date:  2017-05-04       Impact factor: 3.616

9.  Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration.

Authors:  Yasuhiro Koh; Xiaolin Wu; Andrea L Ferris; Kenneth A Matreyek; Steven J Smith; KyeongEun Lee; Vineet N KewalRamani; Stephen H Hughes; Alan Engelman
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

10.  HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Authors:  F Maldarelli; X Wu; L Su; F R Simonetti; W Shao; S Hill; J Spindler; A L Ferris; J W Mellors; M F Kearney; J M Coffin; S H Hughes
Journal:  Science       Date:  2014-06-26       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.